Corcept’s cancer drug meets main goal in late-stage trial

By Thomson Reuters Jan 22, 2026 | 8:11 AM

Jan 22 (Reuters) – ‍Corcept Therapeutics said ‌on ‌Thursday that its experimental cancer ‍drug met the ‍main goal in ‍a late-stage ‍study.

(Reporting ‍by Sahil Pandey ⁠in Bengaluru; ‌Editing by Shailesh ⁠Kuber)